Evidence map›Paper›PMID 32737133›Full record

ArticleApplied and environmental microbiology2020

Mapping the Efficacy and Mode of Action of Ethylzingerone [4-(3-Ethoxy-4-Hydroxyphenyl) Butan-2-One] as an Active Agent against

Laura Rushton, Ahmad Khodr, Florence Menard-Szczebara, Jean-Yves Maillard, Sylvie Cupferman, Eshwar Mahenthiralingam

Open access · hybridAbstract read
In one paragraph

Article in Applied and environmental microbiology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.1field-weighted citation impact, top 69% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Laura RushtonCardiff School of Biosciences, Cardiff University, Cardiff, United Kingdom RushtonL3@cardiff.ac.uk MahenthiralingamE@cardiff.ac.uk.ORCID 0000-0002-4643-6489
Ahmad Khodr *International Microbiology Department, L'Oréal Research and Innovation, Chevilly-Larue, France.
Florence Menard-Szczebara *International Microbiology Department, L'Oréal Research and Innovation, Chevilly-Larue, France.
Jean-Yves MaillardCardiff School of Pharmacy and Pharmaceutical Sciences, Cardiff University, Cardiff, United Kingdom.ORCID 0000-0002-8617-9288
Sylvie CupfermanInternational Microbiology Department, L'Oréal Research and Innovation, Chevilly-Larue, France.
Eshwar MahenthiralingamCardiff School of Biosciences, Cardiff University, Cardiff, United Kingdom RushtonL3@cardiff.ac.uk MahenthiralingamE@cardiff.ac.uk.ORCID 0000-0001-9014-3790
Cardiff University · GBL'Oréal (France) · FR

Funding

Medical Research Council MR/L015080/1
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Anti-Bacterial AgentsBurkholderiaMicrobial Sensitivity TestsPhenylbutyratesAnti-Bacterial Agentsgamma-hydroxy-gamma-ethyl-gamma-phenylbutyramidePhenylbutyratesBurkholderiaethylzingeronegenomicsmechanisms of resistancepreservative

Identifiers

PMID32737133
PMCPMC7499027
OpenAlexW3046769154

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.